<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="Evaluates acute lymphoblastic leukemia maintenance therapy practice at patient and cohort level.">
<title>Acute Lymphoblastic Leukemia Maintenance Therapy Analysis • allMT</title>
<script src="deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet">
<script src="deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="pkgdown.js"></script><meta property="og:title" content="Acute Lymphoblastic Leukemia Maintenance Therapy Analysis">
<meta property="og:description" content="Evaluates acute lymphoblastic leukemia maintenance therapy practice at patient and cohort level.">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="index.html">allMT</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.0.9000</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item">
  <a class="nav-link" href="articles/allMT.html">Get started</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="reference/index.html">Reference</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="news/index.html">Changelog</a>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/tmungle/allMT/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-home">
<div class="row">
  <main id="main" class="col-md-9"><div class="section level1">
<div class="page-header"><h1 id="allmt">allMT<a class="anchor" aria-label="anchor" href="#allmt"></a>
</h1></div>
<!-- badges: start -->

<!-- badges: end -->
<div class="section level2">
<h2 id="introduction">Introduction<a class="anchor" aria-label="anchor" href="#introduction"></a>
</h2>
<p>Acute lymphoblastic leukemia (ALL) studies across the globe have shown that delivering optimal maintenance therapy (MT) is crucial to achieve better treatment outcomes <a href="#ref-schmiegelow2014mercaptopurine">[1]</a>. Delivering optimal MT includes prescribing maximum tolerated doses of 6-mercaptopurine (6MP) and methotraxate (MTX) based on patient’s blood counts (absolute neutrophil count (ANC), platelet count (PLT) and hemoglobin (HB)). In view of this, the <em>allMT</em> package was created to analyse and visualize the MT data (ANC/PLT/HB/6MP/MTX) for single patient or a given cohort at any center<a class="footnote-ref" tabindex="0" data-bs-toggle="popover" data-bs-content='&lt;p&gt;The work was initiated as part of Tushar Mungle’s PhD work at IIT Kharagpur &lt;a href="#ref-mungle2020modelling"&gt;[2]&lt;/a&gt; and then continued at TTCRC, Tata Medical Center, Kolkata.&lt;/p&gt;'><sup>1</sup></a>. The package was developed considering the ICiCLe-ALL-14 protocol <a href="#ref-das2022protocol">[3]</a> as default. It can be used to analyze data from centers with different MT protocols where in the user will need to alter the function defined ipnut argument/parameters.</p>
</div>
<div class="section level2">
<h2 id="package">Package<a class="anchor" aria-label="anchor" href="#package"></a>
</h2>
<p>Using this package the user may:</p>
<ol style="list-style-type: decimal">
<li><p>Convert maintenance sheets (Tata Medical Center Kolkata, India format or user dependent) into a cleaner, single csv with longitudinal data for each patient.</p></li>
<li>
<p>Analyze MT <a href="#ref-mungle2020modelling">[2]</a></p>
<ul>
<li>
<p>At an individual patient level</p>
<ul>
<li><p>To track patient’s MT progression during or after therapy.</p></li>
<li><p>To track patient’s cycle-by-cycle MT progression during or after the therapy using summary measure (SM) weighted mean (6MP*MTX) vs weighted mean ANC parameters in a scatterplot.</p></li>
<li><p>Asses hematological toxicities - neutropenia, thrombocytopenia and anemia during MT.</p></li>
<li><p>Evaluate median time to first 6MP dose increase for the cohort.</p></li>
<li><p>Evaluate real time dosing decisions (stop, reduce or increase) by the physicians during MT based on MT dosing guidelines <a href="#ref-mungle2020modelling">[2]</a></p></li>
</ul>
</li>
<li>
<p>At cohort level</p>
<ul>
<li><p>SM plot to analyze MT for a given cohort defined by the user. SM is evaluated for each patient and plotted together to represent the entire cohort.</p></li>
<li><p>Compare SM for two or more cohort defined by the user to evaluate MT practice. Cohort comparisons can include clinical interventions, year-wise evolution, patients treated by two different set of physicians, or as user see it fit.</p></li>
<li><p>Asses hematological toxicities - neutropenia, thrombocytopenia and anemia during MT.</p></li>
<li><p>Plot depicting median time to first 6MP dose increase for the cohort.</p></li>
<li><p>Evaluate real time dosing decisions (stop, reduce or increase) by the physicians during MT based on MT dosing guidelines <a href="#ref-mungle2020modelling">[2]</a></p></li>
</ul>
</li>
</ul>
</li>
</ol>
<!-- You'll still need to render `README.Rmd` regularly, to keep `README.md` up-to-date. `devtools::build_readme()` is handy for this. You could also use GitHub Actions to re-render `README.Rmd` every time you push. An example workflow can be found here: <https://github.com/r-lib/actions/tree/v1/examples>. -->
</div>
<div class="section level2">
<h2 id="installation">Installation<a class="anchor" aria-label="anchor" href="#installation"></a>
</h2>
<p>You can install the development version of allMT from <a href="https://github.com/" class="external-link">GitHub</a> with:</p>
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># install.packages("devtools")</span></span>
<span><span class="fu">devtools</span><span class="fu">::</span><span class="fu">install_github</span><span class="op">(</span><span class="st">"tmungle/allMT"</span><span class="op">)</span></span></code></pre></div>
</div>
<div class="section level2">
<h2 id="ethics-approval-statement-for-data">Ethics approval statement for data<a class="anchor" aria-label="anchor" href="#ethics-approval-statement-for-data"></a>
</h2>
<p>The anonymized clinical data set refers to patients treated on the ICiCLe-ALL-14 treatment protocol at the Tata Medical Center Kolkata (institutional review board approval EC/TMC/12/13 for the treatment protocol). Funding support for the ICiCLe-ALL-14 clinical study (Clinical Trials Registry-India reference CTRI/2015/12/006434) was provided by the National Cancer Grid (2016/001; 2016-) and the Indian Council of Medical Research (79/159/2015/NCD-III; 2017-19)</p>
</div>
<div class="section level2">
<h2 id="contribution">Contribution<a class="anchor" aria-label="anchor" href="#contribution"></a>
</h2>
<p>By abiding to <a href="https://www.contributor-covenant.org/version/2/1/code_of_conduct/" class="external-link">Contributor Code of Conduct</a>, contribution to <code>allMT</code> in any form (bug fixes/code modification/new code development) is welcomed.</p>
</div>
<div class="section level2">
<h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<div id="refs" class="references csl-bib-body">
<div id="ref-schmiegelow2014mercaptopurine" class="csl-entry">
<div class="csl-left-margin">[1] </div>
<div class="csl-right-inline">K. Schmiegelow, S. N. Nielsen, T. L. Frandsen, and J. Nersting, “Mercaptopurine/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: Clinical facts and fiction,” <em>Journal of pediatric hematology/oncology</em>, vol. 36, no. 7, p. 503, 2014.</div>
</div>
<div id="ref-mungle2020modelling" class="csl-entry">
<div class="csl-left-margin">[2] </div>
<div class="csl-right-inline">T. D. Mungle, “Modelling clinical decision processes to optimise maintenance chemotherapy in children with acute lymphoblastic leukaemia,” PhD thesis, IIT Kharagpur, 2020.</div>
</div>
<div id="ref-das2022protocol" class="csl-entry">
<div class="csl-left-margin">[3] </div>
<div class="csl-right-inline">N. Das <em>et al.</em>, “Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): A prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in india,” <em>Trials</em>, vol. 23, no. 1, pp. 1–20, 2022.</div>
</div>
</div>
</div>
</div>


  </main><aside class="col-md-3"><div class="links">
<h2 data-toc-skip>Links</h2>
<ul class="list-unstyled">
<li><a href="https://github.com/tmungle/allMT/" class="external-link">Browse source code</a></li>
<li><a href="https://github.com/tmungle/allMT/issues" class="external-link">Report a bug</a></li>
</ul>
</div>

<div class="license">
<h2 data-toc-skip>License</h2>
<ul class="list-unstyled">
<li><a href="LICENSE.html">Full license</a></li>
<li><small>GPL (&gt;= 3)</small></li>
</ul>
</div>


<div class="citation">
<h2 data-toc-skip>Citation</h2>
<ul class="list-unstyled">
<li><a href="authors.html#citation">Citing allMT</a></li>
</ul>
</div>

<div class="developers">
<h2 data-toc-skip>Developers</h2>
<ul class="list-unstyled">
<li>Tushar Mungle <br><small class="roles"> Author, maintainer </small> <a href="https://orcid.org/0000-0002-2109-3248" target="orcid.widget" aria-label="ORCID" class="external-link"><span class="fab fa-orcid orcid" aria-hidden="true"></span></a> </li>
<li>Ananya Mahadevan <br><small class="roles"> Author </small> <a href="https://orcid.org/0000-0002-7555-6084" target="orcid.widget" aria-label="ORCID" class="external-link"><span class="fab fa-orcid orcid" aria-hidden="true"></span></a> </li>
<li>Shekhar Krishnan <br><small class="roles"> Author </small> <a href="https://orcid.org/0000-0002-6769-3847" target="orcid.widget" aria-label="ORCID" class="external-link"><span class="fab fa-orcid orcid" aria-hidden="true"></span></a> </li>
</ul>
</div>

<div class="dev-status">
<h2 data-toc-skip>Dev status</h2>
<ul class="list-unstyled">
<li><a href="https://github.com/tmungle/allMT/actions/workflows/R-CMD-check.yaml" class="external-link"><img src="https://github.com/tmungle/allMT/actions/workflows/R-CMD-check.yaml/badge.svg" alt="R-CMD-check"></a></li>
</ul>
</div>

  </aside>
</div>


    <footer><div class="pkgdown-footer-left">
  <p></p>
<p>Developed by Tushar Mungle, Ananya Mahadevan, Shekhar Krishnan.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer>
</div>

  

  

  </body>
</html>
